Typewriter Launches with $56 Million for All-RNA Gene Insertion
Typewriter Therapeutics emerged from stealth with a $56 million Series A led by AN Venture Partners and RA Capital Management. The Cambridge-Tokyo startup is developing a two-component, lipid-nanoparticle-delivered RNA system intended to insert full…
